Unknown OBSERVATIONAL NCT03996941

Harm Reduction Program For Informal PrEP Users In A Community-based Setting (seguiPrEP) (seguiPrEP)

Harm Reduction Program For Informal PrEP Users In A Community-based Setting

Sponsor: BCN Checkpoint

Conditions Adherence, Medication HIV Infections HIV/AIDS Preexposure Prophylaxis Sexually Transmitted Diseases Side Effect of Drug Vaccination

Interventions Harm reduction of informal PrEP use PrEP follow up based on point of care testing

Updated 7 times since 2019 Last updated: Jul 6, 2019 Started: Jul 5, 2019 Primary completion: Sep 1, 2024 Completion: Sep 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03996941, this observational or N/A phase trial focuses on Adherence, Medication and HIV Infections and remains ongoing. Sponsored by BCN Checkpoint, it has been updated 7 times since 2019, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Mar 2025 — Present [monthly]

Unknown
Oct 2024 — Mar 2025 [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Oct 2024 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jan 2021 — Jul 2024 [monthly]

Recruiting

▶ Show 2 earlier versions

Aug 2019 — Jan 2021 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Jul 2019 — Aug 2019 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

BCN Checkpoint
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Projecte dels NOMS Hispanosida

Data source: BCN Checkpoint

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Barcelona, Spain